Real-World Experience Using Intravitreal Brolucizumab Alone or in Combination with Aflibercept in the Management of Neovascular Age-Related Macular Degeneration

PURPOSE: To evaluate real-world experience using intravitreal brolucizumab (IVBr), alone or in combination with aflibercept, in eyes with neovascular age-related macular degeneration (nAMD) treated previously with other inhibitors of VEGF (anti-VEGF). METHODS: This was a retrospective study of all e...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Neesurg, Fong, Rodney D, Wilson, Machelle, Moussa, Kareem, Emami-Naeini, Parisa, Moshiri, Ala, Yiu, Glenn, Park, Susanna S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984903/
https://www.ncbi.nlm.nih.gov/pubmed/36880020
http://dx.doi.org/10.2147/OPTH.S399590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984903/
https://www.ncbi.nlm.nih.gov/pubmed/36880020
http://dx.doi.org/10.2147/OPTH.S399590

Ejemplares similares